Susquehanna International Group, LLP Acumen Pharmaceuticals, Inc. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 110,976 shares of ABOS stock, worth $132,061. This represents 0.0% of its overall portfolio holdings.
Number of Shares
110,976
Previous 75,888
46.24%
Holding current value
$132,061
Previous $130,000
6.15%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ABOS
# of Institutions
83Shares Held
38.5MCall Options Held
39.1KPut Options Held
53.4K-
Ra Capital Management, L.P. Boston, MA14.9MShares$17.8 Million0.34% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$4.07 Million1.6% of portfolio
-
Franklin Resources Inc San Mateo, CA3.14MShares$3.74 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$2.57 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.94MShares$2.31 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $48.2M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...